Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Merant

Article Abstract:

Merant is a computer services and software company that has issued two profit warnings during 15 months. The company needs to replace revenue lost from the end of Y2k business. merant was created through a merger between Intersolv and MicroFocus, which has led to a need for rebranding. The company benefits from a leading position in the market for the company's two key businesses, software development tools, and 'change management software products'. The company is involved in e-commerce, but there is stiff competition in this area.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
Merant

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Vocalis

Article Abstract:

Vocalis should benefit from the growth of the speech recognition market, and from a deal with British Telecommunications. The company reported a drop in sales for 1999.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
Vocalis Group PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cadcentre

Article Abstract:

Cadecentre is a global leader in plant design software and has reported good interim results, though could be affected by an economic slowdown.

Publisher: FT Business
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 2000
Cadcentre

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Computer software industry, Software industry, Software, Information technology services, Computer services industry, Information technology services industry
Similar abstracts:
  • Abstracts: Charting: a course. Great minds.... Try before you buy
  • Abstracts: State tax trends
  • Abstracts: Capital appreciation. Snakes and ladders. High rise living
  • Abstracts: Cantab Pharmaceuticals. Merck and Co
  • Abstracts: BAA. Fast rise could mean hard landing for TBI
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.